United Therapeutics Corporation (Nasdaq: UTHR) reports Q3 EPS of $0.50, 8 cents worse than estimates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE